On September 16, Guanzi Private Equity Fund Management (Hangzhou) Co., Ltd. was registered through the filing, according to the official website of the China-Based Association. Enquiries found that the actual controller behind the private equity fund is the founder of Farmer's Mountain Springs Zhong Wei.
On September 19th, With a fortune of $62.6 billion (about 404.4 billion yuan), Mr. Zhong topped the Forbes list of China's richest people and returned to the top of the rich list, according to the Forbes Real-Time Rich List.
Zhong Wei also wants to do PE
According to the filings of the China Foundation Association, guanzi Private Equity Fund is registered address for the West Lake District of Hangzhou, Zhejiang Province, the company was founded on March 23, the registered capital of 30 million yuan, the nature of the company is a domestic-funded enterprises. At present, the number of executives of the company is 2 and the number of employees is 6, of which 4 are qualified to work in the fund.
Further inquiries by venture capital daily reporters found that the majority shareholder of Guanzi Private Equity Fund is Health Hall Co., Ltd., with a 100% stake, while Zhong Qi's stake in Health Hall is as high as 98.38 percent, which means that Zhong Qi is the owner of this low-key private equity fund.
As a heavyweight entrepreneur, the farmer's mountain spring under the control of Zhong Yu is known as "The Water Maotai". On September 8, 2020, Farmer's Hill Springs landed on the Hong Kong Stock Exchange and opened higher on its first day of listing at HK$39.8 per share, with a market capitalisation of HK$445.292 billion, equivalent to 2.5 Mengniu, 1.5 Yili or 5 Master Kang.
Zhong Wei is not only the founder and largest shareholder of Farmer's Mountain Springs, but also the founder of Health Hall Co., Ltd., another company, Wantai Bio is also a star of the capital market.
In April, Wantai Bio, which has a "first domestic HPV vaccine" halo, landed on the Shanghai Stock Exchange, soaring from an offering price of 12.6 yuan per share to 191.08 yuan per share, a 14-fold increase in its share price and now valued at more than 116 billion yuan.
According to the equity structure, Zhong Wei directly owns 78.8 million shares of Wantai Bio and 24.708 million shares indirectly through Health Hall, with a total holding of 75% of the total share capital. With The share price of Wantai Bio soaring, the value of Zhong's fortune has soared by 87 billion yuan.
In this context, as the super-rich Zhong Wei, at the helm of the Guanzi private equity fund, what investment will be made in the future, it is worth paying attention to.
Or move into biomedicine and new consumption
Enquiries found that Zhong Qi's existing enterprise layout two pieces: First, health hall Co., Ltd., with health hall turtle pills, flowers and capsules and other brands;
As a result, venture capitalists have speculated that Zhong Will at least focus on biomedicine and new consumption in the future.
In the case of biomedicine, Wantai Bio itself has an HPV vaccine. In the first half of this year, Wantai Bio's operating income was RMB1,964 million, up 132% YoY, and net profit was RMB720 million, up 195.92% YoY. Despite such good results, it does not mean that Chung has no ambitions in vaccine research and development.
A total of 2442 companies are currently in the field of vaccine research and development in China. In these companies, there is no bell of the heart, worthy of attention.
In fact, after the listing of biopharmaceutical companies, reinvestment in other companies in the industrial chain is not a few examples, Fosun Pharma (600196) is a typical.
Venture Capital Daily reporter inquiries found that the company, which includes pharmaceutical manufacturing, medical services, medical equipment and other businesses, has so far 124 foreign investment incidents.
Fosun Pharmaceuticals has invested in as many as nine cases so far this year. In terms of investment rounds, whether it's round C, seed wheel, angel wheel, or even privatization, there are participants, and the invested companies are in the biomedical field. This means that Fosun Pharma, which Mr Guo heads, is expanding its main business into an aircraft carrier by investing in it.
Since this road has been passed, the vision is unique, acting as a maverick Zhong Qi, and then take this road is not very surprising.
It is worth mentioning that on September 3rd, the North Exchange was established, and management has been disclosing relevant supporting information in recent days. The latest news shows that Gao Yu, Ali has been killed into the new three boards. In the differentiated competition with the Shanghai Stock Exchange and Shenzhen Stock Exchange, the North Exchange should create a number of "special new" small giants, of which the opportunity should not be underestimated.
Then there's the new consumption. Wahaha Ventures is also recently established, venture capitalists believe that Zong Qinghou is 75 years old can also enter the venture capital, 67-year-old Zhong Wei is not under the words.
"The big probability of a private equity fund is in the consumer sector, but it is not clear whether it will only focus on the main business. "Analysis of the above venture capitalists.
However, the capital market people interviewed by the venture capital company believe that Wahaha venture capital should be to raise more funds, around Wahaha's main business investment, but from Zhong's past entrepreneurial experience and vision pattern, compared to Zong Qinghou, perhaps more courage. Either way, the super entrepreneur has more to do after laying out his private equity fund.